March 7, 2019

The University of Pittsburgh announced that Pitt innovators were issued seven  U.S. patents in February 2019.

Featured Patent: U.S. 10,195,252 “Recruitment of Mesenchymal Cells Using Controlled Release Systems”

Steven Little, Chairman of the Department of Chemical and Petroleum Engineering, and colleagues, have developed a system for releasing appropriate chemokines that mimics the body’s natural process to attract mesenchymal stem cells to a desired location. This discovery offers potential treatments for diseases of inflammation including rheumatoid arthritis or psoriasis, or inflammatory conditions such as inflammatory bowel disease or atherosclerosis.

For more information on this innovation, contact Janice Panza at jpanza@innovation.pitt.edu.

 

Below is a list of all patents issued to Pitt innovators in February 2019. To search the database of all Pitt innovations available for licensing, click here.

Patent
Number
Title   Inventor(s)   Licensing Manager      Status
 
10,195,252 Recruitment of Mesenchymal Cells Using Controlled Release Systems Riccardo Gottardi; Steven Little; Daniel Desantis; Mintai Hwang Janice Panza Available for Licensing
 
10,201,575 Oncolytic HSV Vector Joseph Glorioso; Hiroaki Uchida; Justus Cohen; Paola Grandi Maria Vanegas Licensed
 
10,203,389 Method and System for Monitoring Glucose Transport and Metabolism by Spin-Locking Magnetic Resonance Tao Jin; Seonggi Kim; Hunter Mehrens; Kristy Hendrich Robert Racunas Available for Licensing
 
10,208,125 Anti-Mucin 1 Binding Agents and Uses Thereof Olivera Finn; Robert Schoen; Shuji Sato; Wan Cheung; Roberto Polakiewicz Andrew Remes Available for Licensing
 
10,213,334 Apparatus and Method for Modulating Sleep Eric Nofzinger; Jeffrey Schirm; Damian Rippole; Craig Reynolds; Robert Tucker Janice Panza Licensed
 
10,213,526 Methods for Preparation of a Terminally Sterilized Hydrogel Derived from Extracellular Matrix Timothy Keane; Stephen Badylak; Christopher Dearth; Neill Turner Alex Ducruet Licensed
 
10,213,417 Fatty Acids as Anti-Inflammatory Agents Bruce Freeman Andrew Remes Licensed